Sana Biotechnology, Inc.

Historical 13F Holders

Symbol
SANA
CUSIP
799566104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 799566104 since 12/18/2024, newest first.

Filer % of Class Filed
ARCH Venture Fund IX, L.P. 13G/A Amendment 5
15.4% 8/14/2026
Event 6/30/2026
RA Capital Management, L.P. 13G
6.3% 5/21/2026
Event 5/14/2026
BlackRock, Inc. 13G 5.1% 1/21/2026
Event 12/31/2025
ARCH Venture Fund IX, L.P. 13G/A Amendment 4
17.3% 11/14/2025
Event 9/30/2025
BlackRock, Inc. 13G/A Amendment 1 4.9% 4/25/2025
Event 3/31/2025
Vanguard Group Inc 13G/A Amendment 2 4.8% 1/31/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 5.01 k $14.6 k
2026 Q2 223 185 M $827 M
2026 Q1 209 164 M $473 M
2025 Q4 210 160 M $652 M
2025 Q3 188 166 M $589 M
2025 Q2 164 146 M $399 M
2025 Q1 170 149 M $252 M
2024 Q4 179 158 M $259 M
2024 Q3 174 154 M $643 M
2024 Q2 166 151 M $824 M
2024 Q1 163 150 M $1.50 B
2023 Q4 141 127 M $519 M
2023 Q3 141 128 M $493 M
2023 Q2 129 135 M $804 M
2023 Q1 123 131 M $427 M
2022 Q4 126 135 M $534 M
2022 Q3 130 128 M $770 M
2022 Q2 120 126 M $808 M
2022 Q1 121 120 M $987 M
2021 Q4 113 112 M $1.73 B
2021 Q3 93 110 M $2.48 B
2021 Q2 84 98.3 M $1.93 B
2021 Q1 81 92.5 M $3.10 B